Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

NCT07331506 is registered in ClinicalTrials.gov with Oncoliq US Inc as lead sponsor.

NCT NCT07331506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07331506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Lead sponsor
Oncoliq US Inc
Phase
Observational
Overall status
Recruiting
Start date
October 17, 2025
Completion date
February 28, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (early breast cancer), breast cancer - ductal carcinoma in situ (dcis), breast cancer - female, breast cancer - infiltrating ductal carcinoma, breast cancer detection, breast cancer early stage breast cancer (stage 1-3), breast cancer female, breast cancer with low to intermediate her2 expression